Search Results 321-330 of 386 for ❌어코드 【위너보증.com / 가입코드 9122】 토지노추천 ❌

  1. A Study of TAK-981 in Combination with Rituximab in Participants with Relapsed/Refractory (r/r) CD20-positive (CD20+) Non-Hodgkin Lymphoma (NHL) - Mayo Clinic

    There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study ...

  2. A Study Investigating DNA-damage Response Agents in Molecularly Altered Advanced Cancer - Mayo Clinic

    There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study ...

  3. A Study Evaluating the Efficacy and Safety of Obinutuzumab in Participants With Primary Membranous Nephropathy - Mayo Clinic

    Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to ...

  4. CD19-Directed CAR-T Cell Therapy for the Treatment of Relapsed/​Refractory B Cell Malignancies - Mayo Clinic

    Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to ...

  5. A Study to Assess the Effectiveness and Safety of Brensocatib in Participants With Non-Cystic Fibrosis Bronchiectasis - Mayo Clinic

    There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study ...

  6. Risk Score Predicts Angioplasty Outcomes - Mayo Clinic News Network

    "We've been interested in prediction of outcomes after coronary angioplasty and stent procedures for some time,” says Mayo Clinic Cardiologist, Dr. Charanjit ...

  7. CJNJ-67652000 and Prednisone for the Treatment of Men With Metastatic Castration-Resistant Prostate Cancer and SPOP Gene Mutations - Mayo Clinic

    CJNJ-67652000 (niraparib/abiraterone acetate fixed-dose combination) is a drug which stops certain cancer cells from being able to repair themselves from damage ...

  8. Study to Evaluate the Efficacy and Safety of Lutathera in Patients with Grade 2 and Grade 3 Advanced GEP-NET - Mayo Clinic

    There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study ...

  9. Rectal cancer - Doctors and departments - Mayo Clinic

    Learn about the symptoms, causes and prevention of this cancer that starts in the rectum. Treatments include surgery, radiation therapy and chemotherapy.

  10. Biomarker Modulation and the Inhibition of NKT1 Cells by Oral GRI-0621 in Patients With IPF - Mayo Clinic

    There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study ...